An Examination of the Glucose Management Indicator in Young Children with Type 1 Diabetes

Alexandra D Monzon1, Susana R Patton2, Mark Clements3

  • 1Clinical Child Psychology Program, University of Kansas, Lawrence, KS, USA.

Insights

A new formula for the Glucose Management Indicator (GMI) shows strong correlation with HbA1c in young children with type 1 diabetes (T1D), especially with shorter continuous glucose monitor (CGM) data periods.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Diabetes Technology

Background:

  • Previous Glucose Management Indicator (GMI) formulas were not validated in young children with type 1 diabetes (T1D).
  • Continuous glucose monitoring (CGM) data is increasingly used for diabetes management metrics.

Purpose of the Study:

  • To develop and validate a young child-specific GMI formula using CGM data.
  • To assess the relationship between GMI and HbA1c in children aged 0-6 years with T1D.

Main Methods:

  • Extracted CGM data from 215 children with T1D (0-6 years).
  • Compared a previously established GMI formula with a new child-specific GMI equation.
  • Analyzed CGM data from sampling periods of 3-27 days prior to HbA1c measurement.

Main Results:

  • The young child-specific GMI formula showed higher correlations with HbA1c using 18 or fewer days of CGM data.
  • No significant differences were found between the formulas using 21-27 days of CGM data.
  • A strong overall relationship exists between GMI estimates and HbA1c in young children with T1D.

Conclusions:

  • The young child-specific GMI formula may be beneficial for studies using less than 18 days of CGM data.
  • Researchers and clinicians should consider optimizing CGM data collection periods for metric validity.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
496
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
652
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K